Why Rhabdomyolysis Causes Acute Kidney Injury
Rhabdomyolysis damages the kidneys through four primary mechanisms: myoglobin-induced direct tubular toxicity via oxidative stress, physical obstruction of renal tubules by myoglobin casts, renal vasoconstriction leading to hypoperfusion, and systemic inflammatory activation that exacerbates kidney damage 1, 2.
Primary Pathogenic Mechanisms
1. Myoglobin-Mediated Direct Toxicity
When skeletal muscle breaks down, myoglobin is released into the circulation and filtered by the kidneys. Myoglobin itself is directly nephrotoxic through generation of reactive oxygen species and lipid peroxidation, causing oxidative injury to tubular epithelial cells 1, 2. This oxidative damage triggers cellular apoptosis and necrosis in the proximal tubules, where myoglobin accumulates.
2. Tubular Obstruction by Cast Formation
Myoglobin precipitates in the renal tubular lumen, forming obstructive casts that block urine flow 3, 4. This precipitation is enhanced in acidic urine conditions—a critical clinical point since lower urine pH significantly correlates with AKI development 5. The physical obstruction increases intratubular pressure and reduces glomerular filtration.
3. Renal Vasoconstriction and Hypoperfusion
The release of muscle cell contents triggers intrarenal vasoconstriction, reducing renal blood flow and causing ischemic tubular injury 3, 4. This vasoconstriction is mediated by multiple factors including endothelial dysfunction and local inflammatory mediators 2. The combination of direct toxicity and ischemia creates a "double-hit" to the tubular cells.
4. Systemic Inflammatory Response
Rhabdomyolysis triggers a systemic inflammatory cascade with cytokine release that amplifies kidney damage 1. This inflammatory response contributes to endothelial dysfunction, increased vascular permeability, and further tubular injury beyond the direct effects of myoglobin.
Clinical Context and Risk Factors
AKI occurs in 10-50% of patients with severe rhabdomyolysis, with the wide range reflecting varying severity 1. In tertiary care settings, 60% of hospitalized rhabdomyolysis patients develop AKI, with higher risk in older patients and those with cardiovascular/metabolic comorbidities 5. The severity ranges from mild enzyme elevation to requiring renal replacement therapy in approximately 12-21.5% of cases 5, 6.
Important Clinical Pitfalls
The belief that myoglobin alone causes AKI is oversimplified 7. While myoglobin plays a central role, the decision to initiate renal replacement therapy should not be based solely on myoglobin or creatine kinase levels 7. The injury results from the combined effects of all four mechanisms described above, not just myoglobin toxicity.
Acidic urine significantly worsens myoglobin precipitation, which is why urine alkalinization has been theoretically advocated, though current evidence doesn't show clear benefit over aggressive fluid resuscitation alone 8, 5.
The release of other intracellular contents—including potassium, phosphate, and creatine kinase—creates additional metabolic derangements (hyperkalemia, hyperphosphatemia, hypocalcemia) that complicate the clinical picture but are secondary to the primary renal injury mechanisms 1, 3.